The size of India’s cardiac and anti-diabetes drug markets has witnessed significant expansion, more than tripling in the past decade, according to a new report by Pharmarack. The report indicates that the anti-diabetes market, which was valued at approximately Rs 5,000 crore in 2014, has surged to nearly Rs 17,000 crore today.
Read MoreThe study, titled Uncovering the Hidden Link: PCOS and Its Impact on Hair Thinning and Loss, was conducted between 2020 and 2024 and involved 150,000 patients treated with QR678's innovative treatment
Read MoreThe findings come amid global debates over the use of NNSs for weight management and diabetes control, with recent WHO guidelines raising concerns primarily for non-diabetic individuals
Read More